This week in pschedelics: FDA asks the public to weigh in on ibogaine clinical studies; Gabon wants its cut of the ibogaine boom
Plus: The risks and benefits of five psychedelics; and Scholar argues for more religious perspectives in psychedelic studies
Read more: https://bit.ly/4hUGPoo
